BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35228421)

  • 61. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
    Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
    Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
    [TBL] [Abstract][Full Text] [Related]  

  • 63.
    Hemrom A; Tupalli A; Alavi A; Kumar R
    PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlation of BRAF mutation and SUV
    Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
    Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME
    Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
    Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
    Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Utility of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Visceral Leishmaniasis: Case Report and Literature Review.
    Pinnegar HP; Sánchez-Montalvá A; Barios Profitos M; Bosch-Nicolau P; Salvador F; Molina I
    Am J Trop Med Hyg; 2021 Jan; 104(3):934-944. PubMed ID: 33534763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.
    Alam MS; Fu L; Ren YY; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS; Wang Z
    Medicine (Baltimore); 2016 Dec; 95(52):e5579. PubMed ID: 28033252
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of
    Hyeon CW; Yi HK; Kim EK; Park SJ; Lee SC; Park SW; Oh JK; Choi JY; Chang SA
    Sci Rep; 2020 Dec; 10(1):21524. PubMed ID: 33299053
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical value of
    Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
    J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
    [No Abstract]   [Full Text] [Related]  

  • 75. The Diagnostic Value of
    Liu J; Li C; Yang X; Lu X; Zhang M; Qian L; Wang W; Kan Y; Yang J
    Contrast Media Mol Imaging; 2022; 2022():7556315. PubMed ID: 35082556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fluorodeoxyglucose positron emission tomography-computed tomography findings in a first series of 10 patients with polyarteritis nodosa.
    Fagart A; Machet T; Collet G; Quéméneur T; Ben Ticha R; Verstraete M; Le Gouellec N; Demailly F; Rousselin C
    Rheumatology (Oxford); 2022 Apr; 61(4):1663-1668. PubMed ID: 34302460
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
    Shen G; Liang M; Su M; Kuang A
    Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical utility of
    Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
    Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
    Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
    Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.